Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,335.30 -19.12 -0.12%
S&P 500 1,666.29 -1.18 -0.07%
Nasdaq 3,496.43 -2.53 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,824.50 +6.51 0.23%
FTSE 100 6,755.63 +32.57 0.48%
DAX 8,455.83 +57.83 0.69%
Ticker Volume Price Price Delta
Nikkei 15,360.80 +222.69 1.47%
Hang Seng 23,493.00 +410.35 1.78%
S&P/ASX 200 5,209.04 +28.26 0.55%
  • Exchange: NASDAQ CM
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

Prana Biotechnology Ltd

+ Add to Watchlist

PRAN:US

2.3700 USD 0.0638 2.77%

As of 17:20:00 ET on 05/20/2013.

Company Profile for Prana Biotechnology Ltd (PRAN)

Prana Biotechnology Limited is an Australian biotechnology company which researches and develops therapeutic drugs used for treatment of Alzheimer's Disease and other age-related degenerative disorders such as Parkinson's Disease and cataracts.

Contact Information

Prana Biotechnology Ltd

Suite 2
1233 High Street
Armadale, VIC 3143
Australia
Phone: 61-3-9824-8166
Fax: 61-3-9824-8161

Key Executives for Prana Biotechnology Ltd (PRAN)

Geoffrey P KemplerChairman/CEO/FounderRichard RevelinsCFO/Secretary
Diane AngusChief Operating OfficerRudolph E Tanzi "Rudy"Chief Scientific Advisor

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil